No abstract available.
Cervix Uteri* ; Female ; Radiotherapy* ; Troleandomycin*

OBJECTIVES: It is interesting that the term "Tao" is seen in the Bible of Korean revised version, because Tao is the essential part of traditional Korean culture. Korean culture has 5000 years of history rooted in the humanitarian ideal that means devotion to the welfare of mankind. Such humanitarian ideal had accepted, digested and finally recreated many religions and ideas without conflict. Because understanding the patient's culture is important in the psychiatric practice, it is worthwhile to compare the Tao in the Bible and in the traditional culture. This will lead us to understand the Bible more accurately, and understanding the Bible can broaden our view toward the traditional Korean culture. METHODS: The authors searched the term "Tao" in the Bible of Korean Revised Version and compared it with the Biblia Hebrica Stuttgatensia, and Novum Testatum Graece to detect the original expressions of Tao. The meaning of Hebrew or Greek original expressions were compared with English expressions of The Holy Bible, the King James Version. RESULTS: Tao was recorded 85 times in the Bible of Korean Revised Version. The majority of original expressions were "derek" (43 times) in Hebrew Old Testaments, and "hodos" (14 times) in Greek New Testament. The majority of English expressions corresponding to Tao were "way" or "ways" (59 times). "Derek" means the commandments of God. "Hodos" means the way of Jesus Christ. CONCLUSION: "Derek" and "hodos" commonly mean the righteousness and sanctification required to human with the berith (testament) of God. Tao in the Bible of Korean Revised Version is similar to Tao in the traditional culture in the viewpoint of enlightenment. Korean psychotherapy can be elaborated further with the acceptance of Western psychotherapy on the basis of deep understanding of Korean traditional culture, such as Tao.
Bible* ; Humans ; Korea ; Psychotherapy ; Troleandomycin*

PURPOSE: Thyroid-Associated Orbitopathy (TAO) presents with highly variable clinical characteristics. We hypothesize that the underlying thyroid status predisposes a patient to different clinical characteristics of TAO. METHODS: We retrospectively studied the clinical data of 385 patients from the New York area who were referred to our clinic and diagnosed with TAO from Jan 1990 to Dec 2000. We divided the 385 patients into three groups: Graves' hyperthyroid, euthyroid, and hypothyroid, and analyzed them statistically. RESULTS: Three hundred thirty-one (86%) patients were hyperthyroid, 25 (6.5%) were euthyroid, and 29 (7.5%) were hypothyroid. The average age of TAO presentation in each group was 46.7, 46.1, and 49.9 years, respectively. The female-male ratio in each group was 5.25, 3.17, 13.5:1, respectively (p>0.05). The average time from thyroid disease to TAO in the hyperthyroid and hypothyroid groups was 16.6 and 38 months, respectively (p<0.05). The hyperthyroid group had more proptosis (76.1 vs. 41.4%, p=0.0001<0.05) than the hypothyroid group. CONCLUSIONS: TAO has different clinical characteristics depending on thyroid status. The hyperthyroid group has a short disease interval and more severe clinical course of TAO than the hypothyroid group.
Exophthalmos ; Humans ; Phenotype* ; Retrospective Studies ; Thyroid Diseases ; Thyroid Gland* ; Troleandomycin

PURPOSE: The same autoimmune process is thought to cause thyroid associated ophthalmopathy (TAO) and Graves' disease. The aim of this study is to determine hether thyroid autoantibody is related to the development of thyroid associated ophthalmopathy. METHODS: A retrospective chart analysis was performed on patients with a newly diagnosed Graves' disease, who presented to our ophthalmology clinic between January 2006 and December 2009. Thyroid autoantibody titers were obtained at the time of diagnosis and were used to determine the presence or absence of TAO. In addition, any correlations between thyroid autoantibodies were analyzed in patients with TAO. RESULTS: Thyroid autoantibody levels correlated with the development of TAO. Fifty-eight (69%) out of 84 patients with positive thyroid-stimulating hormone receptor antibody (TRAB) levels at the time of diagnosis had TAO. Only 50 (51%) of the 99 patients with negative TRAB levels had TAO. This difference between the two groups was statistically significant (odds ratio, OR=2.2, p=0.013). A statistically significant correlation with the development of TAO was also found in thyroid peroxidase antibody (TPOAb) and anti-thyroglobulin antibody (TgAb), respectively (OR=0.5, p=0.317; OR=0.3, p=<0.001). In patients with TAO, the correlation between TPOAb and TgAb levels was very high (r=0.64, p=<0.001). CONCLUSIONS: A significant association was determined to exist between the development of TAO and thyroid autoantibody level. This result demonstrates the clinical utility of thyroid autoantibody for the diagnosis of TAO in patients with newly diagnosed Graves' disease.
Autoantibodies ; Graves Disease ; Graves Ophthalmopathy ; Humans ; Iodide Peroxidase ; Ophthalmology ; Retrospective Studies ; Thyroid Gland ; Thyrotropin ; Troleandomycin

PURPOSE: To evaluate the effect of orbital decompression surgery on quality of life in thyroid-associated ophthalmopathy (TAO) patients. METHODS: From August 2014 to December 2015, 80 patients diagnosed with TAO at our clinic were retrospectively analyzed. The patients were divided into 2 groups: 30 patients who underwent orbital decompression surgery and 50 patients who did not receive surgery. The Korean version of the Grave's ophthalmopathy specific quality of life (GO-QoL) questionnaire was completed by all patients. We compared questionnaire scores between groups and analyzed demographic and clinical factors affecting change in GO-QoL. RESULTS: The patients who underwent orbital decompression had lower mean GO-QoL score for appearance in comparison with patients without orbital decompression (p < 0.001). The mean GO-QoL score for appearance was increased from 28.8 ± 17.1 to 51.5 ± 18.8 after orbital decompression (p = 0.024). The mean GO-QoL score for visual function was not different between the patients who did not receive surgery and the orbital decompression group. The mean GO-QoL score for visual function was not changed after orbital decompression. There was a significant relation between postoperative proptosis degree and change in GO-QoL score for appearance after orbital decompression. CONCLUSIONS: GO-QoL score for appearance was significantly improved after orbital decompression surgery, and psychological interventions should be considered to enhance the quality of life outcomes.
Decompression* ; Exophthalmos ; Graves Ophthalmopathy* ; Humans ; Orbit* ; Quality of Life* ; Retrospective Studies ; Troleandomycin

PURPOSE: To compare the intraocular pressure (IOP) measured using Goldmann-applanation tonometry (GAT) and Tonopen® tonometry and to evaluate the factors influencing the measurement difference in patients with thyroid-associated ophthalmopathy (TAO)-related restrictive strabismus. METHODS: In 50 eyes of 50 patients who were diagnosed with TAO, IOP measurements were taken using both GAT and a Tonopen® and were subsequently compared between the devices. Factors influencing the measurement difference between the devices were determined, including the restriction of eyeball movement, eyeball deviation, exophthalmometry, central corneal thickness, refractive errors, and blood thyroid hormone levels. RESULTS: In the TAO patients, the GAT-measured IOP was higher than for Tonopen® (16.1 ± 4.7 vs. 13.8 ± 4.5 mmHg, respectively, p < 0.001). As the restriction of vertical eyeball movement increased, the IOP difference between the devices also increased (p = 0.037). The absolute IOP difference between the devices was positively correlated with restrictions in vertical eyeball movement (p = 0.027), degree of vertical strabismus (p = 0.021), and central corneal thickness (p ≤ 0.031). CONCLUSIONS: In patients with TAO accompanying vertical eyeball movement restriction, potential errors in IOP measurements should be considered between the different IOP-measuring devices.
Graves Ophthalmopathy* ; Humans ; Intraocular Pressure* ; Manometry* ; Refractive Errors ; Strabismus* ; Thyroid Gland ; Troleandomycin

OBJECTIVE: The basic concepts and methods applied in the techniques of Taoistic meditation, Yang- Sheng-Sul are analyzed and interpreted from the medico-psychological viewpoint with special reference to the descriptions on Yang-Sheng in the Korean classics of traditional medicine, Dong-Ui-Bo-Gam. RESULTS AND CONCLUSION: 'Dong-Ui-Bo-Gam' has adopted mainly the Taoistic concepts of body as microcosm and concepts of three basic vital forces of Ching, Chi, Shen, three fields of Tan, the incorruptible essence and its circulating routes in the body. The Taoistic breathing techniques Bok-Ki and physical exercises Do-In are based upon the belief on the metaphysical views of body and life. The concepts of three vital forces Ching, Chi, Shen the nurturing of which is regarded as the ultimate goal of Taoistic Yang-Sheng are taken into consideration. These concepts can be comparable to the concept of 'psychoid function' in terms of Jung, the intermediator between soma and psyche. The concepts of Ch(n Shim(Heaven's Heart), Tao, Tan(the corruptible body), Tae-Shik(the fetal breath) represent the symbols of Self in terms of analytical psychology of Jung. Yang-Sheng-Sul can be regarded, in comparison with the Western alchemy, as an alchemical opus performed within the field of body by means of both imagination and physical exercises to achieve the state of immortality which is reflecting partly the symbolic manifestations of the self actualization in Jungian term. Authors also reviewed the results of experimental researches of Taoistic meditation on its physiologic effects and found the necessity for a more elaborated researches and investigations in this concern.
Alchemy ; Carisoprodol ; Exercise ; Imagination ; Medicine, Korean Traditional* ; Medicine, Traditional ; Meditation* ; Psychology ; Respiration ; Triacetoneamine-N-Oxyl ; Troleandomycin

From July 1979 through March 1985, 112 patients with carcinoma of the uterine cervix were treated by whole pelvis irradiation and intracavitary radiation with Cs-37. The treatment consisted of 3600rad-200rad to the whole pelvis by parallel opposing portals, 5 days per week, 180-00rad per day. Parametrial boost with 400-00rad was given in 60 patients. 2 intracavitary Cs-37 radiation using TAO applicator were done with 7-0 days interval. Total treatment times were 40-5 days with average 52 days. Total dose of radiation to point A varied from 6820 to 10500rad with average 8388rad and to point B from 4850 to 6899rad with average 5898rad. All patients had follow up from 6 months to 75 months and median follow up of 31 months. 9(8%) had stage Ib, 14(12.5%) had stage IIa, 50(44.6%) had stage llb, 33(29.5%) had stage III, 6(5.4%) had stage IV. 110 patients had squamous cell carcinoma and 2 patients had adenocarcinoma. 5 year actuarial survival rates were 61.8% for the entire group, 84.6% for stage Ib, 77.8% for stage IIa, 56.7% for stage IIb, 60% for stage III, 33.3% for stage IV. RT dose to medial parametrium (point A) below 8000rad resulted in 7/18(38.9%) failure (=death) in contrast to 25/94 (26.5%) failure with dose over 800rad. RT dose to lateral parametrium (point B) below 6000rad yielded 20/63 (34.9%) failure compared to 10/49 (20.4%) failure with dose over 6000rad. Poor survival group of age were between 40-9 years with failure of 14/41 (34.1%). There was no increased failure rate below age of 40 with failure of 2/11 (13.9%). The results suggest that survival is as good as other published data, and that higher doses over 8000rad to point A and 6000rad to point B should be delivered.
Adenocarcinoma ; Carcinoma, Squamous Cell ; Cervix Uteri* ; Female ; Follow-Up Studies ; Humans ; Pelvis ; Survival Rate ; Troleandomycin

PURPOSE: To evaluate the clinical outcomes of balanced deep lateral and medial orbital wall decompression and to estimate surgical effects using computed tomography (CT) images in Korean patients with thyroid-associated ophthalmopathy (TAO). METHODS: Retrospective chart review was conducted in TAO patients with exophthalmos who underwent balanced deep lateral and medial orbital wall decompression. Exophthalmos was measured preoperatively and postoperatively at 1 and 3 months. Postoperative complications were evaluated in all study periods. In addition, decompressed bone volume was estimated using CT images. Thereafter, decompression volume in each decompressed orbital wall was analyzed to evaluate the surgical effect and predictability. RESULTS: Twenty-four patients (48 orbits) with an average age of 34.08 ± 7.03 years were evaluated. The mean preoperative and postoperative exophthalmos at 1 and 3 months was 18.91 ± 1.43, 15.10 ± 1.53, and 14.91 ± 1.49 mm, respectively. Bony decompression volume was 0.80 ± 0.29 cm3 at the medial wall and 0.68 ± 0.23 cm3 at the deep lateral wall. Postoperative complications included strabismus (one patient, 2.08%), upper eyelid fold change (four patients, 8.33%), and dysesthesia (four patients, 8.33%). Postsurgical exophthalmos reduction was more highly correlated with the deep lateral wall than the medial wall. CONCLUSIONS: In TAO patients with exophthalmos, balanced deep lateral and medial orbital wall decompression is a good surgical method with a low-risk of complications. In addition, deep lateral wall decompression has higher surgical predictability than medial wall decompression, as seen with CT analysis.
Decompression* ; Exophthalmos ; Eyelids ; Graves Ophthalmopathy ; Humans ; Orbit* ; Paresthesia ; Postoperative Complications ; Retrospective Studies ; Strabismus ; Troleandomycin

PURPOSE: To evaluate the clinical features of dry eye in thyroid-associated ophthalmopathy (TAO) according to disease activity and analyze the related factors. METHODS: This study included 157 patients diagnosed with TAO and dry eye between March 2009 and March 2015. According to the clinical activity score (CAS), TAO patients were divided into inactive (CAS < 3) and active (CAS ≥ 3) groups. Clinical features included age, sex, visual acuity, proptosis, palpebral fissure width, orbital computed tomography (CT) findings, thyroid hormones, and ocular surface parameters including tear film break-up time (TFBUT), Schirmer tests, keratoepitheliopathy scores, and ocular surface disease index (OSDI) were obtained and compared between the groups. In addition, correlations between clinical features and ocular surface parameters were analyzed in both groups. RESULTS: In the inactive and active TAO groups, CAS was 1.24 ± 0.69 and 4.23 ± 1.13, respectively (p = 0.001). Thyrotropin-binding inhibitory immunoglobulin was significantly higher in the active TAO group than in the inactive TAO group (p = 0.048). On orbital CT, extraocular muscle hypertrophy was more common in the active TAO group than the inactive TAO group (p = 0.020). No significant difference was found in age, sex, visual acuity, free T4, and thyroid-stimulating hormone between the two groups. During analysis of the tear film and ocular surface parameters, TFBUT (p = 0.006) was shorter and OSDI score (p = 0.028) was higher in the active TAO group than the inactive TAO group. TFBUT was negatively correlated with proptosis (r = -0.432, p = 0.001; r = -0.308, p = 0.032) and palpebral fissure width (r = -0.367 p = 0.012; r = -0.312, p = 0.031) in both groups. OSDI was positively correlated with proptosis in the active TAO group (r = 0.301, p = 0.033). CONCLUSIONS: TFBUT was shorter and OSDI score higher in dry eye patients with active TAO than in patients with inactive TAO. The TFBUT was negatively correlated with proptosis and palpebral fissure width in both groups.
Exophthalmos ; Graves Ophthalmopathy* ; Humans ; Hypertrophy ; Immunoglobulins ; Orbit ; Tears ; Thyroid Hormones ; Thyrotropin ; Troleandomycin ; Visual Acuity